2 Ultra-High-Yield Stocks That Thrive When the Market Gets Rough

Colgate-Palmolive and American States Water are highlighted as defensive stocks that have outperformed the S&P 500 this year, returning 9.3% and 5.5% respectively. Colgate generated $3.6B of free cash flow versus $1.8B of dividends and now yields 2.5% after a 1.9% quarterly payout increase, while American States Water posted 10.9% EPS growth to $3.37 and yields 2.7% after an 8.3% dividend hike. The article argues both names should hold up relatively well in a slowdown, especially if the Fed cuts rates further.

Analysis

This is less a call on two specific names than a signal that the market is starting to pay up for balance-sheet durability and visible cash return in a slower-growth, higher-input-cost regime. If energy stays sticky and consumers trade down, the trade should widen between staples/regulated utilities with pricing power and discretionary or cyclicals exposed to margin compression, especially where wage, freight, or tariff pass-through lags. The second-order effect is that defensive dividend compounding becomes more valuable precisely as earnings revisions broaden downward, which can pull incremental capital away from lower-quality yield proxies.

The more interesting setup is in rates sensitivity: utilities and low-beta staples can act like quasi-duration assets when the Fed transitions from “hold” to cutting. That means the key catalyst is not just recession fear, but the market’s repricing of the front end over the next 1-3 months if labor and inflation data deteriorate. In that regime, AWR should outperform broader utilities because its earnings visibility is unusually clean, while CL gets an extra boost from being both defensive and globally diversified versus domestic consumer pressure.

The consensus risk is assuming these are simple bond proxies. If inflation re-accelerates from energy or tariffs, or if long rates rise while the Fed stays on hold, the multiple expansion case for utilities can stall even if fundamentals hold up. For CL, the hidden downside is that defensive demand is not the same as immune demand: private label and trading-down can cap mix, so the stock likely works best as a relative winner, not an absolute momentum name.

The overlooked opportunity is a rotation pair rather than outright longs: defensive cash yield against rate-sensitive or consumer-demand exposed beta. The article’s setup is strongest over the next quarter, before the market has full clarity on policy and growth; after that, if the economy stabilizes, the relative bid for these names should fade and valuation will matter again.

Key Decisions for Investors

• Go long CL vs. short a consumer-discretionary basket for the next 1-3 months; target 5-8% relative outperformance if consumer confidence and margins deteriorate
• Add AWR on pullbacks as a rate-cut hedge over the next 2-6 months; upside is multiple expansion plus dividend carry, but trim if 10Y yields re-accelerate materially
• Use CL as a defensive anchor in equity books, but only as a market-neutral long; avoid chasing absolute upside above fair-value yield parity with the S&P unless growth data worsens further
• Pair long AWR against short a high-duration utility or rate-sensitive REIT ETF if front-end cuts look imminent; expect 200-400 bps spread capture over one Fed-cut cycle
• If inflation re-accelerates, hedge CL/AWR with a short in broad staples/utility proxies rather than exiting outright, because the main risk is multiple compression, not earnings collapse